Business Wire

Siemens and Bentley Systems Collaborate on Process Industries Academy Initiative

12.6.2018 19:44:00 EEST | Business Wire | Press release

Share

(from ACHEMA, World Forum for the Process Industries) − Siemens’ Process Industries and Drives and Digital Factories divisions are teaming up with Bentley Systems’ Bentley Institute to establish a Process Industries Academy that will support the companies’ joint vision for cloud services and digital workflows in engineering and operations. The Process Industries Academy will help organizations to better understand and develop an effective digital strategy across all aspects of the asset lifecycle, based on the practical experience and knowledge of the industry’s leading experts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612006205/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Process Industries Academy helps organizations develop digital strategy best practices based on practical knowledge from industry experts. (Photo: Bentley Systems)

With recent fluctuations in the oil, gas, and global energy markets, and the subsequent impact on related process manufacturing sectors, established ways of working in the process industries are now being challenged across the entire project lifecycle. Fewer capital investments in greenfield projects, and an increased focus on optimizing productivity, performance and utilization of existing assets, have prompted the process industries to examine new ways to increase competitiveness and operating revenues.

An optimal approach to project delivery and asset performance addresses the interactions and balance between an organization’s capabilities, its people, the underlying business processes and methods, all coupled with the latest technology, to consistently improve its business outcomes.

Based on the experience and knowledge of the industry’s leading experts, the Process Industries Academy will provide sessions focusing on real-world examples of the key aspects of a digital approach to capital project delivery and asset operations. Participants will discover how developing a clear digital strategy for improved collaboration, communication, and coordination between project teams creates an ideal environment to optimize information creation and digital workflows.

Eckard Eberle, CEO, Process Automation, Process Industries and Drives Division, Siemens AG, said, “The Process Industries Academy supports the development of industry best-practice approaches, while respecting the culture and traditions within today’s process industries. Our shared vision for the academy is to offer a practical, effective means for asset owners, decision makers, and program and project managers to understand the interactions and balance between teams, processes, and technologies so they can see improved project delivery and asset performance.”

Alan Lamont, vice president of Digital Advancement Academies for Bentley Systems, said, “The Process Industries Academy will offer industry professionals an environment to learn and share practical insights about business process improvements enabled by technology, so they can educate and equip their teams to be more productive and achieve the best outcomes. With academy sessions, we hope to help participants to develop a better understanding of their role and the benefits across the asset lifecycle, with practical, real-world examples of “Going Digital” to advance capital project delivery and asset operations.”

Process Industries Academies will be situated in the following locations to support the global process industry:

  • Karlsruhe, Germany at Siemens’ Process Automation World
  • Houston, Texas, U.S. in Bentley’s Digital Advancement Academy
  • Shanghai, China at Siemens’ Process Industry Center of Excellence

The first academy session is scheduled for November 14, 2018 in Karlsruhe at Siemens Process Automation World. A half-day preview of the Process Industries Academy will be featured during Bentley’s Year in Infrastructure 2018 Conference in London on Monday, October 15.

Caption and image link: The Process Industries Academy will help organizations develop a digital strategy based on practical experience and knowledge from leading experts.
Attribution: Photo courtesy of Bentley Systems

Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide. www.siemens.com

Bentley Institute advances the infrastructure professions by encouraging and supporting going digital. Its initiatives advance and attract current and future infrastructure professionals through continuous learning about technology solutions, as well as project delivery and asset performance best practices. Bentley Institute’s Digital Advancement Academies facilitate an environment and a culture of innovation via awareness sessions, forums, and targeted seminars and working groups, helping to ensure that all project collaborators fully understand the digital processes, standards, and deliverables expected for successful project outcomes. www.bentley.com/learn

Bentley Systems, Incorporated is a global leader dedicated to providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing infrastructure. Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, and is on track to surpass an annual revenue run rate of $700 million. Since 2012, Bentley has invested more than $1 billion in research, development, and acquisitions. www.bentley.com

Bentley and the Bentley logo are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bentley Systems, Incorporated
Press Contact:
Jennifer Maguire
+1 610-458-2695
jennifer.maguire@bentley.com
Follow us on Twitter:
@BentleySystems
or
Siemens AG
Evelyne Kadel
evelyne.kadel@siemens.com
+49 211 69161003

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye